SK26393A3 - 1-[2-arylsulfonylamino)-1-oxoethyl]piperidine derivatives, method of their preparation and their pharmaceutical compositions - Google Patents
1-[2-arylsulfonylamino)-1-oxoethyl]piperidine derivatives, method of their preparation and their pharmaceutical compositions Download PDFInfo
- Publication number
- SK26393A3 SK26393A3 SK263-93A SK26393A SK26393A3 SK 26393 A3 SK26393 A3 SK 26393A3 SK 26393 A SK26393 A SK 26393A SK 26393 A3 SK26393 A3 SK 26393A3
- Authority
- SK
- Slovakia
- Prior art keywords
- group
- formula
- compound
- carbon atoms
- methyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9203828A FR2689130B1 (fr) | 1992-03-30 | 1992-03-30 | Derives de 1-[2 (arylsulfonylamino)ethyl-1-oxo] piperidine, leur preparation et leur application en therapeutique. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SK26393A3 true SK26393A3 (en) | 1993-12-08 |
Family
ID=9428242
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK263-93A SK26393A3 (en) | 1992-03-30 | 1993-03-29 | 1-[2-arylsulfonylamino)-1-oxoethyl]piperidine derivatives, method of their preparation and their pharmaceutical compositions |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US5453430A (de) |
| EP (2) | EP0579277A1 (de) |
| JP (2) | JP2550276B2 (de) |
| KR (1) | KR930019664A (de) |
| CN (1) | CN1076928A (de) |
| AT (1) | ATE161839T1 (de) |
| AU (1) | AU655876B2 (de) |
| CA (1) | CA2092867A1 (de) |
| CZ (1) | CZ52893A3 (de) |
| DE (1) | DE69316068T2 (de) |
| FI (1) | FI931413A (de) |
| FR (1) | FR2689130B1 (de) |
| HU (1) | HUT64758A (de) |
| IL (1) | IL105028A0 (de) |
| MX (1) | MX9301783A (de) |
| NO (2) | NO302572B1 (de) |
| NZ (1) | NZ247277A (de) |
| PL (1) | PL298299A1 (de) |
| SK (1) | SK26393A3 (de) |
| TW (1) | TW234717B (de) |
| ZA (1) | ZA932228B (de) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2689130B1 (fr) | 1992-03-30 | 1994-05-27 | Synthelabo | Derives de 1-[2 (arylsulfonylamino)ethyl-1-oxo] piperidine, leur preparation et leur application en therapeutique. |
| JPH06329627A (ja) * | 1993-05-03 | 1994-11-29 | Bristol Myers Squibb Co | グアニジニル−またはアミジニル−置換ヘテロ環トロンビンインヒビター |
| FR2710066B1 (fr) * | 1993-09-14 | 1995-10-20 | Synthelabo | Dérivés de 1-[2-amino-5-[1-(triphénylméthyl-1H-imidazol-4-yl]-1-oxopentyl]piperidine, leur préparation et leur utilisation comme intermédiaires de synthèse. |
| FR2710061B1 (fr) * | 1993-09-14 | 1995-12-29 | Synthelabo | Acides et chlorures d'acides 1,2,3, 4-tétrahydroquinoléine-8-sulfoniques, et leur utilisation comme intermédiaires de synthèse. |
| FR2718443B1 (fr) * | 1994-04-12 | 1996-05-10 | Synthelabo | Dérivés de 1-[2-[[(3-méthyl-1, 2, 3, 4-tétrahydroquinoléin-8-yl)sulfonyl] amino]-1-oxo-5-(1H-imidazol-4-yl)pentyl]pipéridine, leur préparation et leur application en thérapeutique. |
| FR2718444B1 (fr) * | 1994-04-12 | 1996-05-10 | Synthelabo | Dérivés de (3-méthyl-1, 2, 3, 4-tétrahydroquinoléin-8-yl)sulfonyle, leur préparation et leur application en thérapeutique. |
| FR2718439B3 (fr) * | 1994-04-12 | 1996-02-09 | Synthelabo | Dérivés de l'acide pipécolique, leur préparation et leur utilisation comme intermédiaires de synthèse. |
| FR2718442B1 (fr) * | 1994-04-12 | 1996-05-10 | Synthelabo | Dérivés de 5-(1H-imidazol-4-yl)-1-oxopentylpipéridine, leur préparation et leur application en thérapeutique. |
| DE4424828A1 (de) * | 1994-07-14 | 1996-01-18 | Thomae Gmbh Dr K | Neue substituierte Arylsulfonamide, ihre Herstellung und ihre Verwendung als Arzneimittel |
| FR2727413B1 (fr) * | 1994-11-25 | 1996-12-20 | Synthelabo | Derives de 5-(1h-imidazol-4-yl)-1-oxo-2-(phenylsulfonamino)- pentylpiperidine, leur preparation et leur application en therapeutique |
| FR2728570B1 (fr) * | 1994-12-23 | 1997-04-11 | Synthelabo | Derives de 1-oxo-2-(phenylsulfonylamino)pentylpiperidine, leur preparation et leur application en therapeutique |
| GB9505538D0 (en) * | 1995-03-18 | 1995-05-03 | Ciba Geigy Ag | New compounds |
| US5811402A (en) * | 1996-03-22 | 1998-09-22 | Eli Lilly And Company | Antithrombotic diamides |
| FR2747677B1 (fr) * | 1996-04-22 | 1998-06-05 | Synthelabo | Derives de propargylglycine, leur preparation et leur utilisation comme intermediaires de synthese |
| JP2001500842A (ja) * | 1996-04-22 | 2001-01-23 | サンテラボ | プロパルギルグリシン誘導体、その製造法および合成中間体としてのその使用 |
| FR2747676B1 (fr) * | 1996-04-22 | 1998-06-05 | Synthelabo | Derives de [1-oxo-2-(sulfonylamino)ethyl] piperidine, leur preparation et leur application en therapeutique |
| US5840733A (en) * | 1996-07-01 | 1998-11-24 | Redcell, Canada, Inc. | Methods and compositions for producing novel conjugates of thrombin inhibitors and endogenous carriers resulting in anti-thrombins with extended lifetimes |
| FR2756285B1 (fr) * | 1996-11-22 | 1998-12-18 | Synthelabo | Derives de n-(imidazolylbutyle)benzenesulfonamide, leur preparation et leur application en therapeutique |
| US5773089A (en) * | 1996-12-18 | 1998-06-30 | E. I. Du Pont De Nemours And Company | Process for treating aramid surfaces to be plated |
| FR2765220B1 (fr) * | 1997-06-25 | 1999-07-30 | Synthelabo | Derives de 1-oxo-2-(phenylsulfonyl)aminopentyle, leur preparation et leur application en therapeutique |
| FR2771094B1 (fr) * | 1997-11-19 | 2000-02-04 | Synthelabo | Derives de piperidine-2-carboxylate, leur preparation et leur application en therapeutique |
| JP2008540618A (ja) * | 2005-05-18 | 2008-11-20 | ブルスター，ジークフリート | ソマトスタチン受容体サブタイプ１及び／又は４に選択的なペプチド模倣薬 |
| EP2845587A3 (de) * | 2008-12-22 | 2015-07-29 | Pola Chemical Industries Inc. | Melaninproduktionshemmer |
| CN101794567B (zh) * | 2010-02-10 | 2014-01-01 | 中兴通讯股份有限公司 | 图片加载的方法及终端 |
| CN104098647B (zh) * | 2014-06-24 | 2017-12-08 | 安徽省逸欣铭医药科技有限公司 | 阿加曲班类似物及其制备方法和医药用途 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE48623B1 (en) * | 1978-08-31 | 1985-03-20 | Mitsubishi Chem Ind | Alpha-(n-arylsulfonyl-l-argininamides,processes for their preparation and pharmaceutical compositions containing these substances |
| EP0008596A1 (de) * | 1978-09-04 | 1980-03-19 | DEVINTER Europe S.A. Société anonyme dite: | Verfahren zur Herstellung von 4-Hydroxymethyl-imidazolderivaten aus übereinstimmenden 4-Imidazolkarbonsäureestern |
| SE8203887D0 (sv) * | 1982-06-23 | 1982-06-23 | Kabivitrum Ab | Nya trombininhiberande foreningar |
| DK134687A (da) | 1986-03-17 | 1987-09-18 | Glaxo Group Ltd | Indolderivater |
| CA2043741C (en) * | 1990-06-07 | 2003-04-01 | Kiyofumi Ishikawa | Endothelin antagonistic peptide derivatives |
| FR2689130B1 (fr) | 1992-03-30 | 1994-05-27 | Synthelabo | Derives de 1-[2 (arylsulfonylamino)ethyl-1-oxo] piperidine, leur preparation et leur application en therapeutique. |
-
1992
- 1992-03-30 FR FR9203828A patent/FR2689130B1/fr not_active Expired - Fee Related
-
1993
- 1993-03-11 IL IL105028A patent/IL105028A0/xx unknown
- 1993-03-19 TW TW82101726A patent/TW234717B/zh active
- 1993-03-25 DE DE69316068T patent/DE69316068T2/de not_active Expired - Fee Related
- 1993-03-25 EP EP93114975A patent/EP0579277A1/de not_active Withdrawn
- 1993-03-25 EP EP93400772A patent/EP0565396B1/de not_active Expired - Lifetime
- 1993-03-25 AT AT93400772T patent/ATE161839T1/de not_active IP Right Cessation
- 1993-03-29 HU HU9300915A patent/HUT64758A/hu unknown
- 1993-03-29 JP JP5069846A patent/JP2550276B2/ja not_active Expired - Lifetime
- 1993-03-29 AU AU35560/93A patent/AU655876B2/en not_active Ceased
- 1993-03-29 US US08/037,972 patent/US5453430A/en not_active Expired - Fee Related
- 1993-03-29 CA CA002092867A patent/CA2092867A1/fr not_active Abandoned
- 1993-03-29 NO NO931166A patent/NO302572B1/no unknown
- 1993-03-29 SK SK263-93A patent/SK26393A3/sk unknown
- 1993-03-29 KR KR1019930004980A patent/KR930019664A/ko not_active Application Discontinuation
- 1993-03-29 CZ CZ93528A patent/CZ52893A3/cs unknown
- 1993-03-29 ZA ZA932228A patent/ZA932228B/xx unknown
- 1993-03-29 FI FI931413A patent/FI931413A/fi unknown
- 1993-03-29 PL PL29829993A patent/PL298299A1/xx unknown
- 1993-03-29 NZ NZ247277A patent/NZ247277A/xx unknown
- 1993-03-29 CN CN93103308A patent/CN1076928A/zh active Pending
- 1993-03-30 MX MX9301783A patent/MX9301783A/es unknown
- 1993-11-10 JP JP5281073A patent/JPH0798807B2/ja not_active Expired - Lifetime
-
1997
- 1997-12-05 NO NO975664A patent/NO975664D0/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0565396A1 (de) | 1993-10-13 |
| ZA932228B (en) | 1993-10-28 |
| KR930019664A (ko) | 1993-10-18 |
| MX9301783A (es) | 1994-02-28 |
| NZ247277A (en) | 1995-07-26 |
| FR2689130B1 (fr) | 1994-05-27 |
| FI931413A (fi) | 1993-10-01 |
| AU655876B2 (en) | 1995-01-12 |
| PL298299A1 (en) | 1993-10-18 |
| IL105028A0 (en) | 1993-07-08 |
| DE69316068T2 (de) | 1998-08-13 |
| JPH0798807B2 (ja) | 1995-10-25 |
| EP0565396B1 (de) | 1998-01-07 |
| EP0579277A1 (de) | 1994-01-19 |
| NO302572B1 (no) | 1998-03-23 |
| HUT64758A (en) | 1994-02-28 |
| CN1076928A (zh) | 1993-10-06 |
| NO975664D0 (no) | 1997-12-05 |
| NO931166L (no) | 1993-10-01 |
| NO931166D0 (no) | 1993-03-29 |
| JPH06199807A (ja) | 1994-07-19 |
| DE69316068D1 (de) | 1998-02-12 |
| FI931413A0 (fi) | 1993-03-29 |
| JP2550276B2 (ja) | 1996-11-06 |
| CA2092867A1 (fr) | 1993-10-01 |
| CZ52893A3 (en) | 1994-02-16 |
| NO975664L (no) | 1993-10-01 |
| HU9300915D0 (en) | 1993-06-28 |
| FR2689130A1 (fr) | 1993-10-01 |
| AU3556093A (en) | 1993-10-07 |
| TW234717B (en) | 1994-11-21 |
| ATE161839T1 (de) | 1998-01-15 |
| JPH06157514A (ja) | 1994-06-03 |
| US5453430A (en) | 1995-09-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SK26393A3 (en) | 1-[2-arylsulfonylamino)-1-oxoethyl]piperidine derivatives, method of their preparation and their pharmaceutical compositions | |
| TWI504597B (zh) | 結合於細胞凋亡抑制蛋白（ｉａｐ）之桿狀病毒ｉａｐ重複序列（ｂｉｒ）區域之化合物 | |
| JPH11503418A (ja) | ファルネシル−タンパク質トランスフェラーゼ阻害剤 | |
| TW309512B (de) | ||
| CN102532198A (zh) | 抗病毒的次膦酸酯化合物 | |
| JPH07304750A (ja) | ファルネシルタンパク質トランスフェラーゼのイミダゾール含有抑制剤 | |
| PT90659B (pt) | Processo para a preparacao de inibidores de renina contendo diois | |
| UA60311C2 (uk) | Антагоністи рецептора вітронектину, спосіб одержання цих сполук та фармацевтична композиція | |
| JP2001501577A (ja) | ファルネシル−タンパク質トランスフェラーゼ阻害剤 | |
| JPH04352757A (ja) | アミノ酸誘導体 | |
| JPS6253952A (ja) | レニン阻害剤製造用中間体の立体選択的製法 | |
| EA005532B1 (ru) | Замещенные имидазолы в качестве ингибиторов активированной формы активируемого тромбином ингибитора фибринолиза (tafia) | |
| JPH10506897A (ja) | ファルネシル−タンパク質転移酵素の阻害剤 | |
| TW200806652A (en) | N-hydroxyacrylamide compounds | |
| JPH06505979A (ja) | ベンゾフラン誘導体 | |
| CN104736519B (zh) | 吲哚啉类 | |
| JP6333267B2 (ja) | アザインドリン | |
| CA2075547A1 (en) | Trifluoromethyl-containing pseudopeptides | |
| JPH07285990A (ja) | ホウ素ペプチド誘導体、その製剤および治療的応用 | |
| DK171402B1 (da) | Tripeptidderivater, fremgangsmåde til deres fremstilling og farmaceutiske præparater deraf, især et antihypertensivt middel | |
| JP4192100B2 (ja) | Ｄ−プロリンに対するプロドラッグ | |
| US5753667A (en) | 1-oxo-2- (phenylsulphonylamino) pentylpiperidine derivatives, their preparation and their therapeutic application | |
| JP2002322154A (ja) | 抗真菌化合物 | |
| HRP980216A2 (en) | Therapeutic 1,2,3,4-tetrahydroisoquinolines | |
| JP2002511089A (ja) | 新規なｎ−ベンゼンスルホニル−ｌ−プロリン化合物、その製造法および治療における使用方法 |